These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38815646)

  • 1. Associations of Urine and Plasma Metabolites With Kidney Failure and Death in a Chronic Kidney Disease Cohort.
    Steinbrenner I; Schultheiss UT; Bächle H; Cheng Y; Behning C; Schmid M; Yeo WJ; Yu B; Grams ME; Schlosser P; Stockmann H; Gronwald W; Oefner PJ; Schaeffner E; Eckardt KU; Köttgen A; Sekula P;
    Am J Kidney Dis; 2024 Oct; 84(4):469-481. PubMed ID: 38815646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urine Metabolite Levels, Adverse Kidney Outcomes, and Mortality in CKD Patients: A Metabolome-wide Association Study.
    Steinbrenner I; Schultheiss UT; Kotsis F; Schlosser P; Stockmann H; Mohney RP; Schmid M; Oefner PJ; Eckardt KU; Köttgen A; Sekula P;
    Am J Kidney Dis; 2021 Nov; 78(5):669-677.e1. PubMed ID: 33839201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolomic Markers of Kidney Function Decline in Patients With Diabetes: Evidence From the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Kwan B; Fuhrer T; Zhang J; Darshi M; Van Espen B; Montemayor D; de Boer IH; Dobre M; Hsu CY; Kelly TN; Raj DS; Rao PS; Saraf SL; Scialla J; Waikar SS; Sharma K; Natarajan L;
    Am J Kidney Dis; 2020 Oct; 76(4):511-520. PubMed ID: 32387023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Klotho and Clinical Outcomes in CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Edmonston D; Fuchs MAA; Burke EJ; Isakova T; Wolf M;
    Am J Kidney Dis; 2024 Sep; 84(3):349-360.e1. PubMed ID: 38583756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of the Urine-to-Plasma Urea Ratio With CKD Progression.
    Liu J; Bankir L; Verma A; Waikar SS; Palsson R
    Am J Kidney Dis; 2023 Apr; 81(4):394-405. PubMed ID: 36356680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolites Associated With Uremic Symptoms in Patients With CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Wulczyn KE; Shafi T; Anderson A; Rincon-Choles H; Clish CB; Denburg M; Feldman HI; He J; Hsu CY; Kelly T; Kimmel PL; Mehta R; Nelson RG; Ramachandran V; Ricardo A; Shah VO; Srivastava A; Xie D; Rhee EP; Kalim S;
    Am J Kidney Dis; 2024 Jul; 84(1):49-61.e1. PubMed ID: 38266973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloperoxidase and the Risk of CKD Progression, Cardiovascular Disease, and Death in the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Correa S; Pena-Esparragoza JK; Scovner KM; Waikar SS; Mc Causland FR
    Am J Kidney Dis; 2020 Jul; 76(1):32-41. PubMed ID: 31864821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of kidney disease outcomes with risk factors for CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) study.
    Yang W; Xie D; Anderson AH; Joffe MM; Greene T; Teal V; Hsu CY; Fink JC; He J; Lash JP; Ojo A; Rahman M; Nessel L; Kusek JW; Feldman HI;
    Am J Kidney Dis; 2014 Feb; 63(2):236-43. PubMed ID: 24182662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Urinary Oxalate Excretion With the Risk of Chronic Kidney Disease Progression.
    Waikar SS; Srivastava A; Palsson R; Shafi T; Hsu CY; Sharma K; Lash JP; Chen J; He J; Lieske J; Xie D; Zhang X; Feldman HI; Curhan GC;
    JAMA Intern Med; 2019 Apr; 179(4):542-551. PubMed ID: 30830167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urine neutrophil gelatinase-associated lipocalin and risk of cardiovascular disease and death in CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Liu KD; Yang W; Go AS; Anderson AH; Feldman HI; Fischer MJ; He J; Kallem RR; Kusek JW; Master SR; Miller ER; Rosas SE; Steigerwalt S; Tao K; Weir MR; Hsu CY;
    Am J Kidney Dis; 2015 Feb; 65(2):267-74. PubMed ID: 25311702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uric Acid and the Risks of Kidney Failure and Death in Individuals With CKD.
    Srivastava A; Kaze AD; McMullan CJ; Isakova T; Waikar SS
    Am J Kidney Dis; 2018 Mar; 71(3):362-370. PubMed ID: 29132945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fasting Urinary Osmolality, CKD Progression, and Mortality: A Prospective Observational Study.
    Tabibzadeh N; Wagner S; Metzger M; Flamant M; Houillier P; Boffa JJ; Vrtovsnik F; Thervet E; Stengel B; Haymann JP;
    Am J Kidney Dis; 2019 May; 73(5):596-604. PubMed ID: 30777634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum metabolomic profiling and incident CKD among African Americans.
    Yu B; Zheng Y; Nettleton JA; Alexander D; Coresh J; Boerwinkle E
    Clin J Am Soc Nephrol; 2014 Aug; 9(8):1410-7. PubMed ID: 25011442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Opioids and Nonsteroidal Anti-inflammatory Drugs With Outcomes in CKD: Findings From the CRIC (Chronic Renal Insufficiency Cohort) Study.
    Zhan M; Doerfler RM; Xie D; Chen J; Chen HY; Diamantidis CJ; Rahman M; Ricardo AC; Sondheimer J; Strauss L; Wagner LA; Weir MR; Fink JC;
    Am J Kidney Dis; 2020 Aug; 76(2):184-193. PubMed ID: 32317121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Longitudinal B-Type Natriuretic Peptide Monitoring With Kidney Failure in Patients With CKD: A Cohort Study.
    Oka T; Sakaguchi Y; Hattori K; Asahina Y; Kajimoto S; McCallum W; Tighiouart H; Sarnak MJ; Kaimori JY; Isaka Y
    Am J Kidney Dis; 2023 Nov; 82(5):559-568. PubMed ID: 37354935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frailty and Cardiovascular Outcomes in Adults With CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Hannan M; Chen J; Hsu J; Zhang X; Saunders MR; Brown J; McAdams-DeMarco M; Mohanty MJ; Vyas R; Hajjiri Z; Carmona-Powell E; Meza N; Porter AC; Ricardo AC; Lash JP;
    Am J Kidney Dis; 2024 Feb; 83(2):208-215. PubMed ID: 37741609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung Function and Incident Kidney Disease: The Atherosclerosis Risk in Communities (ARIC) Study.
    Sumida K; Kwak L; Grams ME; Yamagata K; Punjabi NM; Kovesdy CP; Coresh J; Matsushita K
    Am J Kidney Dis; 2017 Nov; 70(5):675-685. PubMed ID: 28754455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Measures of Inflammation and Kidney Function for Prediction of Atherosclerotic Vascular Disease Events and Death in Patients With CKD: Findings From the CRIC Study.
    Amdur RL; Feldman HI; Dominic EA; Anderson AH; Beddhu S; Rahman M; Wolf M; Reilly M; Ojo A; Townsend RR; Go AS; He J; Xie D; Thompson S; Budoff M; Kasner S; Kimmel PL; Kusek JW; Raj DS;
    Am J Kidney Dis; 2019 Mar; 73(3):344-353. PubMed ID: 30545708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between non-malignant monoclonal gammopathy and adverse outcomes in chronic kidney disease: A cohort study.
    Fenton A; Chinnadurai R; Gullapudi L; Kampanis P; Dasgupta I; Ritchie J; Harding S; Ferro CJ; Kalra PA; Taal MW; Cockwell P
    PLoS Med; 2020 Feb; 17(2):e1003050. PubMed ID: 32109242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma Soluble Urokinase Plasminogen Activator Receptor (suPAR) and CKD Progression in Children.
    Weidemann DK; Abraham AG; Roem JL; Furth SL; Warady BA
    Am J Kidney Dis; 2020 Aug; 76(2):194-202. PubMed ID: 31987488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.